Search research articles
Contact Us
Filters
Showing results (101-110 of 123) with videos related to
Page
of 13
Sort By:
Biorxiv : the Preprint Server for Biology
|
February 12, 2026
Histotripsy-initiated immune response synergizes with chemotherapy in a neuroblastoma murine model
Natalia Antonides-Jensen, Muskan Singh, Yuqing Xue, et al.
Cancers
|
May 4, 2026
Histotripsy-Initiated Immune Response Synergizes with Chemotherapy in a Neuroblastoma Murine Model
Natalia Antonides-Jensen, Muskan Singh, Yuqing Xue, et al.
Journal of the National Cancer Institute
|
November 9, 2017
Evaluation of Genetic Predisposition for MYCN-Amplified Neuroblastoma
Eric A Hungate, Mark A Applebaum, Andrew D Skol, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
April 13, 2023
Diffuse Pediatric-type High-grade Glioma Arising in an Ovarian Mature Cystic Teratoma
Lena Elmuti, Julia Amundson, Elise Oberman, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 11, 2024
Targeting DTX2/UFD1-mediated FTO degradation to regulate antitumor immunity
Yan-Hong Cui, Jiangbo Wei, Hao Fan, et al.
Annals of Surgical Oncology
|
March 10, 2016
Is a Wider Margin (2 cm vs. 1 cm) for a 1.01-2.0 mm Melanoma Necessary?
Matthew P Doepker, Zachary J Thompson, Kate J Fisher, et al.
Clinical and Translational Science
|
June 11, 2026
A Bayesian-Based Integrative Bioinformatics Analysis Nominates Oncogenic Drivers in Neuroblastoma
Lin Xu, Arhanti Sadanand, Evan W Neczypor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 22, 2020
Age, Diagnostic Category, Tumor Grade, and Mitosis-Karyorrhexis Index Are Independently Prognostic in Neuroblastoma: An INRG Project
Elizabeth Sokol, Ami V Desai, Mark A Applebaum, et al.
Pediatric Blood & Cancer
|
August 29, 2025
Outcomes for Patients Aged 12-18 Months With Metastatic MYCN Non-Amplified Neuroblastoma and Unfavorable Biologic Features ("Mixed Biology Toddlers"): A Report From the International Neuroblastoma Risk Group (INRG) Project
Mallory R Taylor, James R Anderson, Julie R Park, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 15, 2020
Reply to K. Beiske et al
Elizabeth Sokol, Ami V Desai, Mark A Applebaum, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 123) with videos related to
Sort By:
Page
of 13
Biorxiv : the Preprint Server for Biology
|
February 12, 2026
Histotripsy-initiated immune response synergizes with chemotherapy in a neuroblastoma murine model
Natalia Antonides-Jensen, Muskan Singh, Yuqing Xue, et al.
Cancers
|
May 4, 2026
Histotripsy-Initiated Immune Response Synergizes with Chemotherapy in a Neuroblastoma Murine Model
Natalia Antonides-Jensen, Muskan Singh, Yuqing Xue, et al.
Journal of the National Cancer Institute
|
November 9, 2017
Evaluation of Genetic Predisposition for MYCN-Amplified Neuroblastoma
Eric A Hungate, Mark A Applebaum, Andrew D Skol, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
April 13, 2023
Diffuse Pediatric-type High-grade Glioma Arising in an Ovarian Mature Cystic Teratoma
Lena Elmuti, Julia Amundson, Elise Oberman, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 11, 2024
Targeting DTX2/UFD1-mediated FTO degradation to regulate antitumor immunity
Yan-Hong Cui, Jiangbo Wei, Hao Fan, et al.
Annals of Surgical Oncology
|
March 10, 2016
Is a Wider Margin (2 cm vs. 1 cm) for a 1.01-2.0 mm Melanoma Necessary?
Matthew P Doepker, Zachary J Thompson, Kate J Fisher, et al.
Clinical and Translational Science
|
June 11, 2026
A Bayesian-Based Integrative Bioinformatics Analysis Nominates Oncogenic Drivers in Neuroblastoma
Lin Xu, Arhanti Sadanand, Evan W Neczypor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 22, 2020
Age, Diagnostic Category, Tumor Grade, and Mitosis-Karyorrhexis Index Are Independently Prognostic in Neuroblastoma: An INRG Project
Elizabeth Sokol, Ami V Desai, Mark A Applebaum, et al.
Pediatric Blood & Cancer
|
August 29, 2025
Outcomes for Patients Aged 12-18 Months With Metastatic MYCN Non-Amplified Neuroblastoma and Unfavorable Biologic Features ("Mixed Biology Toddlers"): A Report From the International Neuroblastoma Risk Group (INRG) Project
Mallory R Taylor, James R Anderson, Julie R Park, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 15, 2020
Reply to K. Beiske et al
Elizabeth Sokol, Ami V Desai, Mark A Applebaum, et al.
Page
of 13